Prosecution Insights
Last updated: May 29, 2026

Examiner: PEEBLES, KATHERINE

Tech Center 1600 • Art Units: 1617 1628 1658

This examiner grants 36% of resolved cases

Performance Statistics

36.3%
Allow Rate
-23.7% vs TC avg
565
Total Applications
+49.7%
Interview Lift
1167
Avg Prosecution Days
Based on 490 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
7.8%
§102 Novelty
61.6%
§103 Obviousness
1.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
15962327 COMPOSITIONS WITH ANIONIC AND CATIONIC POLYMERS HAVING IMPROVED BENEFITS Non-Final OA The Procter & Gamble Company
19171664 FERTILIZER COMPOSITION CONTAINING A CARBON-BASED ADDITIVE AND METHODS OF MAKING SAME Final Rejection The Mosaic Company
18705455 SPRAY-DRIED COMPOSITIONS AND METHODS OF PREPARATION Non-Final OA NATIONAL UNIVERSITY OF SINGAPORE
18652169 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS Non-Final OA L'OREAL
18035174 THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF Final Rejection The General Hospital Corporation
17346615 STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS Final Rejection ECOLAB USA INC.
18557650 USE OF PERILLYL ALCOHOL TO ENHANCE LEVO-DOPA DELIVERY Non-Final OA UNIVERSITY OF SOUTHERN CALIFORNIA
17544987 FOAM IN WOUND TREATMENT Non-Final OA Mölnlycke Health Care AB
17798019 COSMETIC PRODUCT Non-Final OA BAKEL S.R.L.
18250065 MODULAR DENDRON MICELLES FOR COMBINATION IMMUNOTHERAPY Non-Final OA Wisconsin Alumni Research Foundation
17782436 FORMULATION COMPRISING STREPTOMYCES SPP. FOR USE IN SEED TREATMENT Final Rejection DANSTAR FERMENT AG
17837891 COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH Non-Final OA Pfizer Inc.
16297194 FORMULATIONS OF VILOXAZINE Final Rejection Supernus Pharmaceuticals, Inc.
18292993 BIODEGRADABLE ALGINATE FILMS Non-Final OA NUTRITION & BIOSCIENCES USA 1, LLC
17601331 COSMETIC PREPARATION CONTAINING ULTRAVIOLET WAVELENGTH CONVERSION MATERIAL AND WATER-SOLUBLE THICKENING AGENT Final Rejection Shiseido Company, Ltd.
18613017 SOLID DISPERSION OF RIFAXIMIN Final Rejection Lupin Limited
18560137 IMMUNOGENIC COMPOSITION Non-Final OA GRIFFITH UNIVERSITY
18433424 Regulator for Highland Barley and Preparation Method and Application Thereof Non-Final OA Institute of Crop Science, Chinese Academy of Agricultural Sciences
18423627 MARINE FEED ATTRACTANTS AND METHODS OF USE Non-Final OA Purina Animal Nutrition LLC
18278176 SURFACE-MODIFIED ZINC OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC PREPARATION, AND METHOD FOR PRODUCING SURFACE-MODIFIED ZINC OXIDE PARTICLES Final Rejection SUMITOMO OSAKA CEMENT CO., LTD.
18362383 TREATMENTS FOR UTERINE FIBROIDS Non-Final OA RESURGE THERAPEUTICS, INC.
18532571 ANTIBACTERIAL COMPOSITION FOR GLASS COATING AND ANTIBACTERIAL GLASS Non-Final OA RIGMAH GLASS Co., Ltd.
18220852 ENCAPSULATION OF PEROXIDES FOR SKIN APPLICATIONS Final Rejection Arkema Inc.
18286843 Poorly Soluble Chain-like Drug-entrapped Polymeric Micelle, and Preparation Method and Use Thereof Non-Final OA Hangzhou Hanjing Biotechnology Co., Ltd
18555277 POMACE LEACHATE HERBICIDE COMPOSITION AND METHODS Non-Final OA JACKSON FAMILY WINES, INC.
18551823 SYNERGISTIC PLANT GROWTH STIMULANT COMPOSITIONS OF POTASSIUM MONO/DI-FORMATE WITH CARBOXYLIC ACIDS Non-Final OA FERTIS INDIA PVT. LTD.
18451361 SYSTEMS, DEVICES, AND FORMULATIONS FOR TIME-PHASED HISTAMINE DELIVERY Non-Final OA AgoneX Biopharmaceuticals, Inc.
18366400 Antipsychotic Injectable Depot Composition Non-Final OA LABORATORIOS FARMACEUTICOS ROVI S.A.
18225397 METHOD FOR TREATMENT OF ROSACEA INCLUDING PATIENT REPORTED OUTCOMES THEREOF Final Rejection Mayne Pharma LLC
18272786 GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF RISPERIDONE Final Rejection Nortiva Bio, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month